DaVita Quarterly Cash Flow Statement
NYSE: DVAHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DaVita free cash flow
In the quarter ended Jun 30, 2026, DaVita generated $490.1 million of operating cash flow and spent $169.8 million on capital expenditures. That left free cash flow of $320.3 million, a free-cash-flow margin of 9.0% of revenue. Free cash flow was up 57.6% from the prior year's $203.1 million.
DaVita returned $181.5 million to shareholders through share repurchases, equal to 57% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
DaVita cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 343.22M | 275.04M | 331.03M | 240.25M | 275.22M | 232.22M | 349.25M | 295.76M | 299.75M | 305.98M | 230.57M | 309.36M |
| Net Income growth (YoY) | +24.71% | +18.44% | -5.22% | -18.77% | -8.18% | -24.11% | +51.47% | -4.40% | +21.66% | +79.28% | +82.10% | +87.84% |
| Depreciation & Amortization | 167.81M | 177.83M | 186.70M | 177.49M | 174.70M | 176.45M | 174.10M | 187.01M | 175.66M | 187.08M | 195.28M | 188.42M |
| Stock-Based Compensation | 26.03M | 28.16M | 38.39M | 38.99M | 32.81M | 29.76M | 27.40M | 26.56M | 24.29M | 24.54M | 30.06M | 27.12M |
| Change in Working Capital | 28.00M | -33.25M | -56.38M | 216.53M | -138.57M | -123.85M | 188.44M | 11.11M | 363.85M | -573.51M | 82.52M | -16.17M |
| Operating Cash Flow | 490.07M | 320.83M | 540.73M | 841.53M | 324.24M | 180.01M | 547.63M | 810.40M | 798.85M | -134.84M | 485.20M | 661.16M |
| Capital Expenditures | -169.82M | -102.02M | -145.43M | -166.09M | -121.09M | -143.26M | -170.66M | -139.05M | -124.72M | -121.02M | -158.97M | -136.81M |
| Investing Cash Flow | -194.25M | -139.09M | -163.13M | -262.52M | -67.17M | -162.14M | -247.97M | -146.49M | -161.76M | -215.21M | -168.30M | -139.85M |
| Share Repurchases | -181.48M | -196.37M | -274.48M | -240.05M | -283.67M | -510.16M | -365.38M | -407.94M | -361.65M | -250.96M | -272.22M | 0 |
| Debt Issued | 1.51B | 1.26B | 940.11M | 482.45M | 3.56B | 633.19M | 676.00K | 3.35B | 1.99B | 1.29B | 6.00K | 331.46M |
| Financing Cash Flow | -270.19M | -213.34M | -414.52M | -582.16M | 4.45M | -382.54M | -565.10M | -7.86M | -563.29M | 319.32M | -403.25M | -394.50M |
| Net Change in Cash | 25.45M | -31.34M | -37.67M | -1.54M | 272.39M | -355.25M | -278.82M | 655.40M | 72.47M | -33.85M | -80.49M | 122.95M |
| Free Cash Flow | 320.25M | 218.81M | 395.30M | 675.44M | 203.15M | 36.75M | 376.97M | 671.36M | 674.12M | -255.85M | 326.23M | 524.36M |
This table shows 12 quarterly periods of DaVita's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DVA's reporting calendar. What is a cash flow statement?